The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Amesimeku, Theophilus
    Pharmacist born in June 1974
    Individual (20 offsprings)
    Officer
    2022-11-14 ~ now
    OF - director → CIF 0
    Mr Theophilus Amesimeku
    Born in June 1974
    Individual (20 offsprings)
    Person with significant control
    2022-11-14 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

CLARKE PHARMACY LIMITED

Standard Industrial Classification
47730 - Dispensing Chemist In Specialised Stores
Brief company account
Par Value of Share
Class 1 ordinary share
12022-11-14 ~ 2023-11-30
Intangible Assets
760,500 GBP2023-11-30
Property, Plant & Equipment
17,098 GBP2023-11-30
Fixed Assets
777,598 GBP2023-11-30
Total Inventories
18,650 GBP2023-11-30
Debtors
38,797 GBP2023-11-30
Cash at bank and in hand
52,193 GBP2023-11-30
Current Assets
109,640 GBP2023-11-30
Net Current Assets/Liabilities
-208,688 GBP2023-11-30
Total Assets Less Current Liabilities
568,910 GBP2023-11-30
Creditors
Non-current
-601,856 GBP2023-11-30
Net Assets/Liabilities
-32,946 GBP2023-11-30
Equity
Called up share capital
100 GBP2023-11-30
Retained earnings (accumulated losses)
-33,046 GBP2023-11-30
Equity
-32,946 GBP2023-11-30
Average Number of Employees
22022-11-14 ~ 2023-11-30
Intangible Assets - Gross Cost
Net goodwill
780,000 GBP2023-11-30
Intangible Assets - Increase From Amortisation Charge for Year
Net goodwill
19,500 GBP2022-11-14 ~ 2023-11-30
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
19,500 GBP2023-11-30
Intangible Assets
Net goodwill
760,500 GBP2023-11-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
17,998 GBP2023-11-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
900 GBP2022-11-14 ~ 2023-11-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
900 GBP2023-11-30
Property, Plant & Equipment
Plant and equipment
17,098 GBP2023-11-30
Trade Debtors/Trade Receivables
Current
11,950 GBP2023-11-30
Amount of value-added tax that is recoverable
Current
13,562 GBP2023-11-30
Prepayments
Current
10,661 GBP2023-11-30
Debtors
Current, Amounts falling due within one year
38,797 GBP2023-11-30
Bank Borrowings/Overdrafts
Current
24,824 GBP2023-11-30
Trade Creditors/Trade Payables
Current
65,774 GBP2023-11-30
Accrued Liabilities
Current
900 GBP2023-11-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2023-11-30
Profit/Loss
Retained earnings (accumulated losses)
-33,046 GBP2022-11-14 ~ 2023-11-30

  • CLARKE PHARMACY LIMITED
    Info
    Registered number 14482746
    1053 London Road, Leigh-on-sea, Essex SS9 3JP
    Private Limited Company incorporated on 2022-11-14 (2 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-13
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.